Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/19/2025

Management of Hypertriglyceridemia

Classification and Risk Assessment

  • The American College of Cardiology recommends that for a 61-year-old female with a triglyceride level of 4.47 mmol/L (approximately 396 mg/dL), medication therapy should be initiated after addressing lifestyle factors and secondary causes, as this level represents moderate hypertriglyceridemia with increased cardiovascular risk 1, 2
  • A triglyceride level of 4.47 mmol/L (396 mg/dL) falls into the moderate hypertriglyceridemia category, which is associated with increased cardiovascular risk but below the threshold for acute pancreatitis concern 3
  • The American College of Cardiology states that at this level, the focus should be on reducing cardiovascular risk rather than preventing pancreatitis 4
  • In adults 40-75 years with moderate hypertriglyceridemia and ASCVD risk ≥7.5%, persistently elevated triglycerides should be considered a factor favoring initiation or intensification of statin therapy, according to the American College of Cardiology 1

Initial Management Approach

  • The American College of Cardiology recommends addressing and treating lifestyle factors, secondary factors, and reviewing medications that may increase triglycerides before initiating medication therapy 1
  • Implementing therapeutic lifestyle changes, including weight reduction, can decrease triglycerides by approximately 20% 3, 5
  • Dietary modifications with reduced carbohydrates, restriction of alcohol consumption, and regular physical activity are recommended 5

Pharmacologic Therapy Options

  • The American College of Cardiology recommends that for moderate hypertriglyceridemia with elevated ASCVD risk, statin therapy should be initiated or intensified 1, 2
  • Statins are the first-line therapy for patients with moderate hypertriglyceridemia and elevated cardiovascular risk, and provide a 10-30% dose-dependent reduction in triglycerides 1, 3

Special Considerations

  • The American College of Cardiology considers conditions specific to women, such as premature menopause and history of pregnancy-associated disorders, when discussing lifestyle intervention and potential benefits of statin therapy 1
  • Women of childbearing age who are treated with statin therapy should use reliable contraception, as recommended by the American College of Cardiology 1